
HemaFAIR Newsletter #4 Is Now Available
We are pleased to announce the release of HemaFAIR Newsletter #4, highlighting the latest developments, achievements, and upcoming activities across the project. In this issue,

We are pleased to announce the release of HemaFAIR Newsletter #4, highlighting the latest developments, achievements, and upcoming activities across the project. In this issue,
The HemaFAIR and HELIOS COST Action successfully concluded the Federated Data Analysis Training School & Hackathon, held in Ayia Napa, Cyprus, from 11–14 May 2026

HemaFAIR continues to strengthen its presence within the international scientific community, with project researcher Maria Xenophontos presenting recent work at the SWAT4HCLS 2026 in Amsterdam.

The HemaFAIR project (Grant Agreement No. 101159589) continues to make strong progress with the development of the Cyprus Haemoglobinopathy Patient Registry. The registry has already

We’re excited to share a new webinar series to help the hemoglobinopathy community understand key data-driven approaches shaping the future of biomedical research and healthcare.

We are pleased to share a new publication developed in collaboration between the HELIOS network and the HemaFAIR project, recently published in Scientific Data. The

Strengthening the role of the patient voice in regulatory science and FAIR data The HemaFAIR consortium has actively contributed to the European Medicines Agency (EMA)

As part of our FAIRification efforts and our strong commitment to Open Access and Open Science, we are happy to share that the training materials
Have a look at the project’s website on this link! You can find information on: HemaFAIR objectives Project Members Announcement of news and events